Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.43 |
| ▸ | ESRRA | P11474 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7558864 | 0.81 | GAA (0.38) | GAAMAPTHSD17B10TP53ALOX15 | |
| SCHEMBL28527519 | 0.79 | LIG1 (0.48) | GAAMAPTHSD17B10TP53ALOX15 | |
| SCHEMBL30790667 | 0.77 | MAPT (0.74) | GAAMAPTHSD17B10TP53ALOX15 | |
| SCHEMBL112507 | 0.77 | MAPT (0.74) | GAAMAPTHSD17B10TP53ALOX15 | |
| SCHEMBL8764887 | 0.75 | MAPT (0.71) | GAAMAPTHSD17B10TP53ALOX15 | |
| Ammonia Solution, Strong SCHEMBL10992665 | 0.75 | MAPT (0.71) | GAAMAPTHSD17B10TP53ALOX15 | |
| Hydrochloric Acid SCHEMBL11745887 | 0.75 | MAPT (0.71) | GAAMAPTHSD17B10TP53ALOX15 | |
| SCHEMBL14314287 | 0.74 | ALDH1A1 (0.54) | GAAMAPTHSD17B10ALDH1A1CFTR | |
| SCHEMBL11064770 | 0.72 | ALDH1A1 (0.54) | GAAMAPTALOX15ALDH1A1NPC1 | |
| SCHEMBL1961155 | 0.72 | HSP90AA1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096551-B2 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| EP-2655346-B1 | PROCESS FOR THE PREPARATION OF 2-(TRIAZINYLCARBONYL)SULFONANILIDES | BAYER IP GMBH (DE) | 2015-01-21 | — | — | EP | disclosed |
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| EP-2655346-A2 | METHOD FOR PRODUCING 2-(TRIAZINYLCARBONYL) SULFONANILIDES | Bayer Intellectual Property GmbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012084857-A2 | METHOD FOR PRODUCING 2-(TRIAZINYLCARBONYL) SULFONANILIDES | BAYER CROPSCIENCE AG (DE) | 2012-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | AOX1, SULT1E1, CBR1 | GAA 1537/4885MAPT 4102/4885HSD17B10 670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.